Applications of 2-Bromo-3-Nitro-4-Picoline in Industrial Manufacturing

2-Bromo-3-Nitro-4-Picoline is a specialized pyridine derivative with clearly defined roles in the industrial synthesis of high-value compounds. As a manufacturer focused on quality and compliance, we provide this raw material to downstream sectors with stringent performance, purity, and regulatory requirements. The following sections detail its use in major industrial applications, each with specific compliance, formulation, production, and final product characteristics.

1. Pharmaceutical Intermediate for Antihypertensive APIs

This compound serves as a key building block in the synthesis pathway for antihypertensive active pharmaceutical ingredients (APIs), particularly in the manufacture of certain beta-blockers. Used in multi-step organic synthesis, it participates as an electrophilic aromatic intermediate during key condensation and cyclization reactions. Pharmaceutical firms value its high assay for minimizing impurity burdens in the final API. Quality teams monitor each step to ensure material provenance meets international regulatory standards.

Industry compliance standards

• ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients)
• EU GMP (EudraLex Volume 4 Part II)
• US FDA 21 CFR Part 210/211
• Ph. Eur. and USP standards for API intermediates

Typical usage ratio

• Employed at 0.6–1.2 molar equivalents relative to the target API nucleus; refined based on reaction yield optimization and impurity profile.

Downstream process integration

• Introduced during the active step of aromatic nitration, followed by halogen-metal exchange and cyclization within multipurpose reactors under controlled temperature and inert atmosphere. Integrated at kilogram to ton-scale batch production, followed by purification and downstream derivatization.

Final product types

• Bulk antihypertensive APIs: Beta-blockers (e.g., precursor to metoprolol and related pyridine-based compounds)
• Intermediates for contract manufacturing organizations (CMOs) supplying pharmaceutical pipelines

2. Agrochemical Synthesis: Herbicide Active Ingredient Development

Formulators in the agrochemical sector use this raw material to synthesize pyridine-based herbicidal actives with targeted weed control functionalities. Its electron-withdrawing substituents provide the necessary reactivity for efficient coupling and ring modification, supporting the creation of advanced herbicide scaffolds that fit current regulatory and environmental safety benchmarks. In most plants, process parameters are closely controlled to avoid byproduct formation.

Industry compliance standards

• FAO/WHO International Code of Conduct on Pesticide Management
• OECD Guidelines for the Testing of Chemicals
• REACH (EC) No 1907/2006
• ISO 9001:2015 for agrochemical manufacturing

Typical usage ratio

• 0.5–0.9 molar equivalents calculated against total batch target mole, adjusted depending on substitution efficiency and process mass intensity (PMI) requirements.

Downstream process integration

• Charged during early-stage heterocycle formation in dedicated synthesis loops; typically enters the main reactor post-solvent charge, followed by amination or further bromination under nitrogen or argon. Purification by recrystallization or distillation precedes next-step functionalization.

Final product types

• Pyridine-based herbicide active ingredients (customized for broadleaf or grass weed control)
• Technical-grade agrochemical intermediates for formulation houses

3. Fine Chemical Precursor for Dye and Pigment Manufacturing

Dye and pigment producers employ this intermediate for the construction of specialty chromophores, particularly those requiring halogenated nitropyridines as starting units. Its precise positioning of bromo and nitro groups supports regioselective couplings and color-brightness development. This raw material delivers consistent performance in successive synthesis steps, reducing batch-to-batch variability, while meeting quality system documentation requirements demanded by textile, plastics, and ink sectors.

Industry compliance standards

• ISO 9001:2015 for quality management in dye manufacturing
• ZDHC Manufacturing Restricted Substances List for textile dyes
• REACH (EC) No 1907/2006 (for European pigment production)
• ASTM D3134-98 (Standard Practice for Chromatographic Testing in Colorants)

Typical usage ratio

• Varies from 1% to 6% by weight of the total organic component mix, tailored according to chromophore yield and intensity requirements during scale-up trials.

Downstream process integration

• Added as the core halogenated precursor in azo or quinoline ring assembly reactors, typically following pre-mixing with organic solvents or dispersing agents. Entry point is after initial solvent charge but prior to high-temperature condensation, then followed by filtration and isolation of the chromophore.

Final product types

• High-stability azo dyes for fiber and polymer coloring
• Specialty pigments used in automotive refinishing and industrial coatings

4. Starting Material for Custom Synthesis in CRO/CDMO Specialty Projects

Chemical research organizations and custom development manufacturers request this material as a core reactant for investigational compounds. Its defined electronic properties allow for high regioselectivity in small-molecule library construction, supporting medicinal chemistry and process scouting. Traceability from synthesis to delivery is maintained throughout the workflow, with batch records tailored to individual project requirements and route risk assessments filed as standard procedure.

Industry compliance standards

• ISO 13485:2016 (for medical device precursors)
• GLP (Good Laboratory Practice) OECD Principles
• SOP-based custom synthesis protocols audited internally
• Supply chain traceability policies under ISO 9001:2015

Typical usage ratio

• 10–200 mg per mmol scale for early-phase R&D; up to 5–10% molar basis in scale-up, depending on step yield and analytical QC feedback from proprietary routes.

Downstream process integration

• Incorporated as the initial halogenated substrate in laboratory or kilo-lab reactors; entered prior to high-pressure/temperature transformations, with reaction monitoring using HPLC and NMR. Project teams adjust addition rates according to real-time reaction controls.

Final product types

• Investigational medicinal chemistry compounds
• Reference standards for synthetic route validation
• Intermediates for high-value patented molecules